Dr. Rajatha Maradi Hemanth Kumar

Detecting Cancer Earlier Than Ever: AI at the Frontline of Precision Oncology

Abstract:

This keynote explores how artificial intelligence is transforming early cancer detection through precision oncology. It highlights advances in multimodal imaging, liquid biopsy analytics, predictive algorithms, and real-time clinical decision support. The session emphasizes AI-driven risk stratification, earlier diagnosis, personalized intervention strategies, and the future integration of intelligent systems into proactive cancer care.

Profile:

Dr. Rajatha Maradi Hemanth Kumar is an accomplished physician, clinical researcher, and healthcare innovator with more than seven years of multidisciplinary medical experience spanning clinical medicine, preventive healthcare, emergency care, chronic disease management, and patient-centered practice. Her professional work integrates evidence-based medicine with emerging advancements in artificial intelligence, precision oncology, and digital health technologies.
Dr. Rajatha has developed a strong academic and research profile through contributions to peer-reviewed and Scopus-indexed publications focusing on predictive oncology, AI-enabled diagnostics, translational medicine, multi-omics integration, radiology-driven analytics, and personalized therapeutics. Her scholarly interests include foundation models, generative AI in healthcare, digital twin oncology, and computational approaches for improving cancer diagnosis, prognosis, and treatment optimization.
In addition to her clinical and research contributions, she has participated in academic conferences, scientific collaborations, and healthcare innovation initiatives aimed at advancing next-generation precision medicine and intelligent cancer care systems globally.